Neurava
Neurology & CNS Therapeutics · Health Care
$6.2Mtotal raised · 4 rounds on record
$1.6Mlatest round · Venture round · Oct 2025 · 12 mo ago
1backers · Elevate Ventures
10+team · employees, estimated range
Overview
Giving back control to patients with uncontrolled epilepsy. At Neurava, we empower individuals with epilepsy to reclaim their lives with confidence and freedom.
Key facts
These are the key facts about Neurava on Alion as of Nov 13, 2026. Neurava is headquartered in West Lafayette, United States. It was founded in 2019. It has raised $6.2M in 4 funding rounds. The latest round is Venture - Series Unknown of $1.6M, announced in 2025.
- Headquarters
- West Lafayette, United StatesAlion company profile, updated Oct 11, 2026
- Founded
- 2019Alion company profile, updated Oct 11, 2026
- Employees
- 10+Alion company profile, an estimated range
- Total raised
- $6.2MSum of 4 equity rounds Alion knows
- Latest round
- Venture - Series Unknown · $1.6M · Oct 15, 2025SEC Form D filing · sec.gov
- Visa sponsorship, United States
- 1 · H-1B filings in 12 monthsUS Department of Labor · latest filing Nov 7, 2025
Official records
Funding and backers
Total raised
$6.2M
4 rounds on record
Latest round
$1.6M
Venture round · Oct 2025 · 12 mo ago
Team
11-50
employees, estimated range
Backers
1
Elevate Ventures
The money's age
Due for its next round
12 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 15, 2025
Raised a round Venture round $1.6M · SEC Form D
Apr 3, 2024
Raised a round Seed $2M · finanzen.net
Dec 22, 2022
Raised a round Venture round $1.9M · SEC Form D
Aug 20, 2021
Raised a round Convertible Note $656k · SEC Form D
2019
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Oct 2025 | $1.6M | — | SEC Form D |
| Seed | Apr 2024 | $2M | — | finanzen.net |
| Venture round | Dec 2022 | $1.9M | — | SEC Form D |
| Convertible Note | Aug 2021 | $656k | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Neurava LLC | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Jay ShahExecutive Officer, DirectorSEC Form D
Vivek GaneshExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Precision Brain Access for Deep Brain Therapies Millions of patients with Parkinson's disease, Alzheimer's disease, brain cancer, epilepsy…
Boldly advancing the next generation of medicines for Alzheimer’s Disease and Related Dementias.
Our mission is to give people with migraine a better life. As a pioneer in the field of medical devices, Salvia BioElectronics is…
Mentari Therapeutics is on a mission to bring freedom from migraine to as many people as possible.
Corporate giving software for growing companies. Employee giving, volunteering, matching gifts, campaigns, and reporting — all in one…
Our Mission. Deliver medicines that transform the lives of patients with neurodegenerative diseases.
Visa sponsorship
1
H-1B filings in 12 months
$153k
Median offered salary
0
Open roles in United States
Who they sponsor
Computer and information systems managers
1
In the register as Neurava Inc., Baltimore, MD
Other sponsors in the same field
Voyager Therapeutics 
Memsel 
TrueBinding
AbbVie
Alert me
US Department of Labor · latest filing Nov 7, 2025 · Visa details by country
People
Jay Shah
Executive Officer, Director
Vivek Ganesh
Executive Officer, Director
Paul Neeb
Director
Mona Chadha
Director
Kristin Eilenberg
Director
Daniel Moore
Director
John Kay
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Elevate VenturesVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors
News
Neurava Awarded $4 Million NIH Blueprint Optimizer Award to Develop SUDEP Risk Stratification Algorithm
Neurava Inc., an innovative medtech startup focused on advanced wearable monitoring solutions for epilepsy, today announced that it has been awarded a $4 million NIH Blueprint MedTech Optimizer award to support the development of a Sudden Unexpected Death
Read more
Report
Neurava annonce l'obtention d'un financement de 4 millions de dollars via le programme NIH Blueprint Optimizer
Read more
Report
Neurava Announces Strategic Additions to Board of Directors: Medical Device Veteran Daniel Moore and Jed Kay, an Elevate Ventures
/PRNewswire/ -- Neurava, a pioneering medical device company at the forefront of epilepsy care and management, is excited to announce that Daniel (Dan) Moore,...
Read more
Report
Neurava raises over $2M to advance life-saving epilepsy monitoring device
/PRNewswire/ -- Neurava announced that it has completed and oversubscribed its Series Seed round, raising $2.26 million. Neurava is developing novel and...
Read more
Report
Neurava raises over $2M to advance life-saving epilepsy monitoring device
Neurava raises over $2M to advance life-saving epilepsy monitoring device
Read more
Report
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
West Lafayette
United States
HQ
Baltimore
United States
HQ
Address
Suite 807, Baltimore, MD 21230
How to cite this page
Alion, "Neurava: key facts", as of Nov 13, 2026. https://alion.io/company/neurava
These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0